The Network consists of 10 partners from 8 Countries (Germany, Denmark, UK, Ireland, Italy, Switzerland and Israel, US).
The clinical and research centers in the Consortium have a renowned international expertise on hip fracture arthroplasty and cell therapy respectively while Pluristem is a lead company in the cell therapy development. All the Partners have been selected for their excellence in the field.
The HIPGEN consortium includes also the Irish CRO ICON that will manage the multicentre clinical trial, the company Be the Partner that has developed the platform for patient data management and the service provider company INN-ACTA that will support the consortium in the coordination, dissemination and exploitation, allowing the scientists to focus on the science and the business developer on business. Finally, the International Osteoporosis foundation gives an added value of the consortium by filling the communication gap between science and patients.
The high degree of synergy among our participants ensures that the program will be successful and that their combined output will be greater than the sum of its parts. The European dimension of the project is an added value of the proposal, in terms of achieving the necessary critical mass (regarding patient enrollment, clinical infrastructures, availability of samples for analysis), financial support and good visibility.
Participant No 1 (Coordinator) | CHARITE | Germany
Charité Universitaetsmedizin Berlin
Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
Participant No 2 | UOXF | United Kingdom
The Chancellor, Masters and Scholars of the University of Oxford
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORM)
Participant No 3 | OUH-DOT | Denmark
Department of Orthopaedic Surgery and Traumatology, Odense University Hospital
Participant No 4 | CREM | Italy
Centro di Ricerca E. Menni, Fondazione Poliambulanza - Istituto Ospedaliero
Participant No 5 | Pluristem | Israel
Participant No 6 - 11 | BTP | US
Be The Partner
Participant No 7 | ICON | Ireland
ICON Clinical research
Participant No 8 | IOF | Switzerland
International Osteoporosis Foundation
Participant No 9 | ALTA | Italy | Terminated
ALTA Ricerca e Sviluppo in Biotecnologie S.r.l.u.
Participant No 10 | OUH-NHS | United Kingdom
Oxford University Hospitals NHS Foundation Trust - United Kingdom
Participant No 12 | INN-ACTA | Italy
Innovation Acta S.r.l.
Dr. Tobias Winkler
Research Coordination, General administration
Project Management, General administration
For any further information on HIPGEN project, do not hesitate to contact us.